Grunebaum et al. (2017) conducted a midazolam-controlled randomized clinical trial to evaluate the use of ketamine for the rapid reduction of suicidal thoughts in major depression.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• ketamine concept
• major depression concept